Showing results (41-50 of 90) with videos related to
Sort By:
Pageof 9
Journal of Atherosclerosis and Thrombosis|November 12, 2025
An Apparent Association of Metabolic Dysfunction-Associated Steatotic Liver Disease with High Levels of Estimated Small Dense LDL Cholesterol in a Japanese PopulationRie Matsumori, Marenao Tanaka, Tatsuya Sato, et al.Circulation Reports|May 12, 2025
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) Is an Independent Risk Factor for the Development of Ischemic Heart Disease - A 10-Year Cohort StudyToshifumi Ogawa, Tatsuya Sato, Marenao Tanaka, et al.Journal of Molecular and Cellular Cardiology|January 21, 2015
Excessive degradation of adenine nucleotides by up-regulated AMP deaminase underlies afterload-induced diastolic dysfunction in the type 2 diabetic heartHidemichi Kouzu, Takayuki Miki, Masaya Tanno, et al.Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography|November 13, 2012
Assessment of left atrial deformation and synchrony by three-dimensional speckle-tracking echocardiography: comparative studies in healthy subjects and patients with atrial fibrillationAtsushi Mochizuki, Satoshi Yuda, Yukiko Oi, et al.Circulation Journal : Official Journal of the Japanese Circulation Society|July 20, 2026
Altered Plasma Urea Cycle Metabolites Are Independently Associated With Frailty in Patients With Heart FailureKatsuhiko Ohori, Toshiyuki Yano, Satoshi Katano, et al.Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography|December 15, 2010
Left ventricular hypertrophy causes different changes in longitudinal, radial, and circumferential mechanics in patients with hypertension: a two-dimensional speckle tracking studyHidemichi Kouzu, Satoshi Yuda, Atsuko Muranaka, et al.Journal of Molecular and Cellular Cardiology|May 8, 2018
Translational regulation by miR-301b upregulates AMP deaminase in diabetic heartsYuki Tatekoshi, Masaya Tanno, Hidemichi Kouzu, et al.Journal of Pharmacological Sciences|July 27, 2024
Contribution of MLKL to the development of doxorubicin-induced cardiomyopathy and its amelioration by rapamycinMasaki Shimizu, Wataru Ohwada, Toshiyuki Yano, et al.Geriatrics & Gerontology International|December 13, 2023
Coexistence of sarcopenia and self-reported weight loss is a powerful predictor of mortality in older patients with heart failureKatsuhiko Ohori, Toshiyuki Yano, Satoshi Katano, et al.ESC Heart Failure|October 30, 2020
Independent link between peripheral artery disease and muscle wasting in patients with heart failureKatsuhiko Ohori, Toshiyuki Yano, Satoshi Katano, et al.Pageof 9